- Home
- YEXT vs SANA Comparison
YEXT vs SANA Comparison
Compare YEXT & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YEXT
- SANA
- Stock Information
- Founded
- YEXT 2006
- SANA 2018
- Country
- YEXT United States
- SANA United States
- Employees
- YEXT N/A
- SANA N/A
- Industry
- YEXT EDP Services
- SANA Medicinal Chemicals and Botanical Products
- Sector
- YEXT Technology
- SANA Health Care
- Exchange
- YEXT Nasdaq
- SANA Nasdaq
- Market Cap
- YEXT 1.0B
- SANA 983.4M
- IPO Year
- YEXT 2017
- SANA 2021
- Fundamental
- Price
- YEXT $8.09
- SANA $3.33
- Analyst Decision
- YEXT Strong Buy
- SANA Strong Buy
- Analyst Count
- YEXT 4
- SANA 5
- Target Price
- YEXT $9.44
- SANA $8.75
- AVG Volume (30 Days)
- YEXT 593.8K
- SANA 6.3M
- Earning Date
- YEXT 09-03-2025
- SANA 08-11-2025
- Dividend Yield
- YEXT N/A
- SANA N/A
- EPS Growth
- YEXT N/A
- SANA N/A
- EPS
- YEXT N/A
- SANA N/A
- Revenue
- YEXT $434,450,000.00
- SANA N/A
- Revenue This Year
- YEXT $8.92
- SANA N/A
- Revenue Next Year
- YEXT $5.14
- SANA N/A
- P/E Ratio
- YEXT N/A
- SANA N/A
- Revenue Growth
- YEXT 8.38
- SANA N/A
- 52 Week Low
- YEXT $4.73
- SANA $1.26
- 52 Week High
- YEXT $9.15
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- YEXT 50.02
- SANA 42.70
- Support Level
- YEXT $7.72
- SANA $2.88
- Resistance Level
- YEXT $8.38
- SANA $3.46
- Average True Range (ATR)
- YEXT 0.28
- SANA 0.29
- MACD
- YEXT -0.01
- SANA -0.15
- Stochastic Oscillator
- YEXT 40.66
- SANA 23.65
About YEXT Yext Inc.
Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.